Treatment of chronic myelogenous leukemia
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size='450' side='right' scene='Imatinib/Imatinib/2' caption='Imatinib, also known as Gleevec ([[2hyy]])' pspeed='8'> | <StructureSection load='' size='450' side='right' scene='Imatinib/Imatinib/2' caption='Imatinib, also known as Gleevec ([[2hyy]])' pspeed='8'> | ||
*[[Imatinib]] | *[[Imatinib]] | ||
| - | + | *[[Nilotinib]] | |
| + | *[[Dasatinib]] | ||
| + | See also: | ||
| + | *[[Anti-cancer drugs]] | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Current revision
| |||||||||||
